Funds holding IMPACT BIOMEDICAL INC
ISIN US45259L2051 · United States
- Fund holders
- 5
- Of which ETFs
- 1 4 other funds
- Value held
- 463.5K $
- Share of capital
- 0.7 % of 107.8M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 706,954 | 424.2K $ | 0.00 % | 0.66 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 41,157 | 17.9K $ | 0.04 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 34,018 | 14.8K $ | 0.03 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 15,054 | 6.6K $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 6 | 3.6 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 797,189 | +43.5 % |
| 2026Q1 | 5 | 0 | 555,508 | +705.5 % |
| 2025Q4 | 5 | -1 | 68,968 | -15.5 % |
| 2025Q3 | 6 | +3 | 81,593 | -35.1 % |
| 2025Q2 | 3 | -4 | 125,632 | -23.3 % |
| 2025Q1 | 7 | +4 | 163,825 | +367.6 % |
| 2024Q4 | 3 | 35,039 |
Institutional managers
17 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 1,192,925 | 716.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 607,897 | 364.7K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 259,946 | 156K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 243,943 | 146.4K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 37,427 | 22.5K $ | as of Mar 31, 2026 |
| UBS Group AG | 32,417 | 19.5K $ | as of Mar 31, 2026 |
| Mason & Associates Inc | 10,000 | 5.9K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 9,274 | 5.6K $ | as of Mar 31, 2026 |
| Global Trust Asset Management, LLC | 1,818 | 1.1K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 353 | 212 $ | as of Mar 31, 2026 |
| FMR LLC | 290 | 174 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 224 | 134 $ | as of Mar 31, 2026 |
| NFSG Corp | 86 | 52 $ | as of Mar 31, 2026 |
| CWM, LLC | 28 | 17 $ | as of Mar 31, 2026 |
| Burk Holdings LLC | 27 | 16 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 3 | 2 $ | as of Mar 31, 2026 |
| Center for Financial Planning, Inc. | 0 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding IMPACT BIOMEDICAL INC". https://titelia.com/en/stocks/impact-biomedical-inc-US45259L2051